awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35043016-FA79EE9C-7E9B-410A-99C9-4C738088B42B
Q35043016-FA79EE9C-7E9B-410A-99C9-4C738088B42B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35043016-FA79EE9C-7E9B-410A-99C9-4C738088B42B
Anti-angiogenic peptides for cancer therapeutics
P2860
Q35043016-FA79EE9C-7E9B-410A-99C9-4C738088B42B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35043016-FA79EE9C-7E9B-410A-99C9-4C738088B42B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f08c62085e1f46b15591e85e91638708b514ea45
P2860
Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH(2)), a beta integrin antagonist, in patients with solid tumours